Literature DB >> 21036642

Use of bisphosphonates to treat severe idiopathic hypercalcaemia in a young Ragdoll cat.

Joanna L Whitney1, Vanessa R D Barrs, Margaret R Wilkinson, Katherine A Briscoe, Julia A Beatty.   

Abstract

A 3-year-old Ragdoll cat was referred for investigation of polyuria, polydipsia, vomiting, weight loss and hypercalcaemia. Serum biochemical abnormalities included total and ionised hypercalcaemia and hypophosphataemia. Following clinical investigations a diagnosis of idiopathic hypercalcaemia was made. Because of the severity of the hypercalcaemia and the associated clinical signs, treatment for hypercalcaemia was commenced with pamidronate. Major electrolyte abnormalities were detected but, remarkably, were accompanied by minimal clinical signs. The cat was subsequently treated with oral alendronate and is clinically normal 15 months later. Reports of the use of bisphosphonates in cats are limited and close monitoring of patients is recommended.
Copyright © 2010 ISFM and AAFP. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036642     DOI: 10.1016/j.jfms.2010.09.011

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  4 in total

1.  Treatment of ionized hypercalcemia in 12 cats (2006-2008) using PO-administered alendronate.

Authors:  B T Hardy; J F de Brito Galvao; T A Green; S R Braudaway; S P DiBartola; L Lord; D J Chew
Journal:  J Vet Intern Med       Date:  2015-01-12       Impact factor: 3.333

2.  Pamidronate disodium for palliative therapy of feline bone-invasive tumors.

Authors:  Jackie M Wypij; David A Heller
Journal:  Vet Med Int       Date:  2014-06-09

3.  Bilateral patellar fractures and increased cortical bone thickness associated with long-term oral alendronate treatment in a cat.

Authors:  Nicola Council; Jon Dyce; Wm Tod Drost; Joao Felipe de Brito Galvao; Thomas J Rosol; Dennis J Chew
Journal:  JFMS Open Rep       Date:  2017-08-29

4.  Medication-related osteonecrosis of the jaw after long-term bisphosphonate treatment in a cat.

Authors:  Melinda J Larson; Ashley B Oakes; Ember Epperson; Dennis J Chew
Journal:  J Vet Intern Med       Date:  2019-01-21       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.